Portable, low-field magnetic resonance imaging (LF-MRI) of the brain may facilitate point-of-
care assessment of patients with Alzheimer's disease (AD) in settings where conventional …

Introduction Magnetic resonance imaging (MRI) is crucial for diagnosing and monitoring of
multiple sclerosis (MS) as it is used to assess lesions in the brain and spinal cord. However …

White matter hyperintensities (WMH) of presumed vascular origin are a magnetic resonance
imaging (MRI)‐based biomarker of cerebral small vessel disease (CSVD). WMH are …

Objective White matter abnormalities in patients with temporal lobe epilepsy (TLE) and
hippocampal sclerosis (HS) are well known. Peak width of skeletonized mean diffusivity …

Background Peak width of skeletonized mean diffusivity (PSMD) is a novel marker of small
vessel disease. This study aimed to investigate the presence of small vessel disease in …

Objective This study aimed to determine whether brain volume at the time of ischemic stroke
injury is a better biomarker for predicting functional outcomes than brain atrophy …

Portable, low-field Magnetic Resonance Imaging (MRI) scanners are increasingly being
deployed in clinical settings. However, critical barriers to their widespread use include low …

Data-driven machine learning has made significant strides in medical image analysis.
However, most existing methods are tailored to specific modalities and assume a particular …

Brain atrophy is one of the most common features of neurodegenerative diseases and is
particularly critical in the early diagnosis of conditions like Alzheimer's and multiple …